FDA product code OQZ: Anti-Mutated Citrullinated Vimentin Igg

OQZ is the FDA product code for anti-mutated citrullinated vimentin igg. It is a Class II device, regulated under 21 CFR 866.5775 and reviewed by the Immunology panel. FDA has cleared 1 510(k) submission under OQZ. The average 510(k) review took 329 days (median 329).

Definition

For the semi-quantitative measurement of IgG class autoantibodies against mutated citrullinated vimentin (MCV) in human serum or plasma.

Classification

FieldValue
Device nameAnti-Mutated Citrullinated Vimentin Igg
Device classClass II
Regulation21 CFR 866.5775
Review panelIM — Immunology
Medical specialtyImmunology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every OQZ clearance

Top OQZ applicants

ApplicantClearancesLatest
Orgentec Diagnostika GmbH12010-07-01

Most recent OQZ clearances

510(k)ApplicantDeviceDecision dateReview days
K092399Orgentec Diagnostika GmbHANTI-MUTATED CITRULLINATED VIMENTIN EIA2010-07-01329

Recalls for OQZ devices

openFDA lists no recalls for product code OQZ.

Frequently asked questions

What is FDA product code OQZ?

OQZ is the FDA product code for anti-mutated citrullinated vimentin igg. It is a Class II device, regulated under 21 CFR 866.5775 and reviewed by the Immunology panel.

What device class is OQZ?

Class II, regulation 21 CFR 866.5775. Typical premarket route: 510(k).

How long does a 510(k) take for product code OQZ?

Across 1 cleared submissions the average was 329 days from receipt to decision (median 329).

Which companies have the most OQZ clearances?

Orgentec Diagnostika GmbH (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times